ニュース

Fierce Pharma31 分
With China approval, Lilly and Innovent's mazdutide breaks into new class for GLP-1 obesity ...
In a breakthrough for incretin medicines, China’s National Medical Products Administration (NMPA) has approved Innovent’s ...
inews.co.uk46 分
GPs swamped by requests for NHS Mounjaro - but no one qualifies
Thousands taking Mounjaro privately are inundating GP surgeries - clogging phone lines, exacerbating the 8am scramble for ...